Abstract
Hypertension is a chronic medical condition where blood pressure is too high. In Bangladesh, the overall incidence of hypertension is rising, like in other developing countries. Recent studies show hypertension can cause other non-communicable diseases such as cardiovascular diseases, strokes, etc. Utilizing information from the Bangladesh Demographic and Health Survey (BDHS) 2017–18, a cross-sectional and spatial analysis was done to determine the prevalence of hypertension. The existence of spatial autocorrelation is evaluated by using Moran’s I statistic, hotspot analysis, cold spot analysis, and influential observation analysis. The study was conducted on the basis of different factors such as gender, place of residence, age, BMI, etc. Among 12,926 people (43.19% men, 56.81% women), the women had a higher total prevalence of hypertension (41.18% (95% CI, 41.35–45.67) compared to the men’s 58.82% (95% CI, 57.16–60.45). Out of the total number of observations, 27.47% had hypertension. Out of all hypertensive people, 57.56% are unaware of their condition, which is very concerning. The study also finds that 28.4% are from urban areas and 71.6% are from rural areas. People living in the Dhaka division had a higher prevalence of hypertension (20.5%), and those in Sylhet had the lowest prevalence of hypertension (6.2%). There also exists a statistically relevant spatial autocorrelation (hypertension: Moran’s I index = 0.27, p<0.001). These are the spatial clustering maps, and according to the LISA cluster map, the Northeast districts are the cold spots (8), while the hotspots (4) are Bagerhat, Rajbari, Pirojpur, and Munshiganj. Approximately more than one-fourth of the adult population of Bangladesh had hypertension. The analysis discovered the hotspots and cold spots of the prevalence of hypertension. These findings could facilitate awareness and treatment of hypertension and therefore serve as support for researchers and policymakers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Secondary data has been used in this study. Hence, ethics statement was not obtained. The Demographic and Health Survey obtained the ethics statement for the dataset before.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in this study can be found by requesting to the Demographic and Health Survey. The dataset can be found at https://dhsprogram.com/data/.